Product Status and Market Potential
Beyond Air Active Pipeline & Market Size
Product | Indication | Development Status |
Key Dates* | US Sales Potential** |
Worldwide Sales Potential** |
---|---|---|---|---|---|
LungFitBRO (Bronchiolitis) | Bronchiolitis | Pilot Phase | Pivotal Study expected during 2020/2021 Winter Launch 2022* |
>$500m Beyond Air to commercialize |
>$1.2b |
*All dates are based on projections and appropriate financing, anticipated first launch on global basis pending appropriate regulatory approvals
**All figures are Company estimates for peak year sales: Global Sales Potential includes US Sales Potential